All In Biotech

Free tool

FAERS Monitor: Cyklokapron

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 019281 or its brand name (Cyklokapron, Tranexamic Acid). Reports on generic versions are filed under their own applications.

Reports

9,075

Serious

8,437

93% of reports

Hospitalization

4,108

Death reported

1,336

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective662
  • off label use657
  • pyrexia373
  • nausea351
  • hypotension340
  • diarrhoea319
  • haemorrhage317
  • vomiting310
  • dyspnoea299
  • pneumonia282
  • febrile neutropenia267
  • headache244
  • anaemia240
  • anaphylactic reaction235
  • fatigue230

Reports by year received

View as table
YearReports
200441
200540
200641
200738
200868
200976
2010158
2011196
2012191
2013185
2014197
2015285
2016311
2017426
2018485
2019679
2020614
2021854
2022872
2023701
2024951
20251,019
2026647

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,045,084 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
anaphylactic reactionSignal2359.98.71,867
febrile neutropeniaSignal2679.48.31,984
haemorrhageSignal3177.06.31,642
hypotensionSignal3403.93.5747
anaemiaSignal2402.92.6303
pyrexiaSignal3732.52.3339
pneumoniaSignal2822.01.8146
off label use6571.71.6215
vomiting3101.51.457
dyspnoea2991.21.112
drug ineffective6621.21.116
diarrhoea3191.11.06
nausea3511.00.90
headache2440.90.83
fatigue2300.70.634

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.